BioAngels

Mid Atlantic Bio Angels (MABA) operates as an angel investor group exclusively focused on new and emerging life science companies. The organization provides early-stage funding and strategic guidance to ventures across therapeutics, diagnostics, medical devices, and digital health. MABA connects startups with accredited investors, facilitating capital access and expert insights within the life science landscape.

MABA was founded in 2012 by Yaniv Sneor, Stephen Goodman, and Bernard Rudnick. Their shared vision identified the specialized capital needs and scientific challenges inherent in early-stage life science development. This insight led to establishing a dedicated investment network capable of supporting ventures within these highly specialized fields.

The group primarily serves life science entrepreneurs seeking initial capital and investors interested in the sector. MABA's core vision involves fostering innovation and accelerating the development of novel solutions across healthcare and biotechnology. By focusing on life sciences, the organization aims to advance medical breakthroughs through strategic early-stage investment.